Topic: Blood Disorders

Incyte, Novartis myelofibrosis trial meets goal

CHICAGO (Reuters) - A second pivotal trial of ruxolitinib, developed by Incyte Corp and Novartis, met its goal of showing that the drug significantly reduces spleen size in myelofibrosis patients.The rare, but potentially deadly, blood cancer is characterized by bone marrow failure, ...

Novartis sees blood cancer drug as blockbuster

ZURICH (Reuters) - Novartis AG's blood cancer drug INC424 could rake in annual sales of $1 billion, the group's head of oncology told Reuters on Tuesday, in a boost to the Swiss drugmaker's cancer pipeline."We believe it can become a very reasonable ...

France sees first 'saviour sibling'

Doctors in France on Monday announced the country's first birth of a "saviour sibling," selected at the embryonic stage to be a close genetic match to save a brother or sister suffering from a fatal inherited disorder.The baby was born at the ...
Plasma donation centers in Fort Worth, Texas need donations to aid local hospitals in fighting blood disorders. Plasma donations are accepted all over the Fort Worth area, and as a donor you are compensated for your time and donations.. In Fort Worth ...
AMGN) today announced the publication of results from the first open-label study to compare Nplate (romiplostim) treatment to standard of care therapies (SOC) in non-splenectomized adult patients with chronic immune thrombocytopenia (ITP). Data also showed that patients receiving SOC therapies required splenectomies ...

Thalassemia

Thalassemia is the name given for a family of blood disorders that affect red blood cell production. Thalassemia is an inherited disorder which most often affects people with Mediterranean or Asian ancestry; however, thalassemia can also be prevalent among people of African ...

Twinkle Dwivedi

Twinkle Dwivedi is a 13-year-old girl from India , who suffers from a rare blood disorder . Girl who bleeds without being cut baffles doctors (September 30, 2008) The disease had a sudden onset in July 2007 , when Dwivedi began bleeding ...

Von Willebrand Disease

Von Willebrand Disease is a family of congenital bleeding disorders caused by abnormal levels or function of a blood protein, called Von Willebrand Factor (VWF). Von Willebrand Disease (February 12, 2007) VWF is an important protein that helps the blood clot, and ...
Romiplostim, a thrombopoietin mimetic, is associated with higher rates of platelet response, lower rates of treatment failure and splenectomy, fewer blood transfusions, less bleeding, and a higher quality of life than standard care among patients with immune thrombocytopenia, according to a study ...
A letter to the editor is presented in response to the article " Inferior Vena Cava Thrombosis in Young Adults - A Review of Two Cases," by B. J. McAree et al, published in the May 2009 issue. We read with interest ...
Previous